Acrivon Therapeutics has acquired ACR-525, a Phase 2-ready oral JAK1 inhibitor, and a PKCθ inhibitor preclinical program from Aqilion AB, marking its expansion into immunology and inflammation (I&I) alongside oncology. ACR-525 is highly selective with potential best-in-class status, targeting eosinophilic esophagitis (EoE) initially, with broader applications in autoimmune diseases like inflammatory bowel disease (IBD). The acquisition supports Acrivon's AI-driven AP3 platform strategy for precision medicine in I&I, aiming for optimized patient selection and biomarker-guided development. A webcast with key opinion leaders is scheduled for November 10, 2026, to discuss these programs.
Acrivon Therapeutics' recent acquisition of immunology and inflammation drug candidates is noted alongside Pluang's Health-sector market snapshot as of Nov 06, 2026 19:41 WIB: out of 150 priced US Health stocks, 52 rose and 90 fell. Notable movers include HALO at USD 117.01 with a 1-day change of -4.84%, SNN at USD 30.70 down 4.09%, and TXG at USD 55.80 down 3.89% with Pluang order activity heavily skewed to selling at 88%.
Nexans has signed a subcontract to deliver a 420 km mass-impregnated 110 kV cable system for the 1 GW, 320 kV Corinth-Kos HVDC interconnection in Greece. This project, awarded to Hellenic Cables and partners, will connect the Dodecanese islands to ma...
Guggenheim analyst Howard Ma raised JFrog's price target to $125, signaling a 67.5% potential upside from its current price of $74.62. JFrog reported strong Q3 2026 results with revenue up 31% year-over-year to $179.2 million, driven by a 60% surge i...
The Indonesia data center market is projected to grow from USD 2.08 billion in 2027 to USD 4.05 billion by 2032, at a CAGR of 14.28%. Growth is fueled by expanding hyperscaler cloud infrastructure, rising digital workloads, increasing demand for colo...
US nonfarm payrolls increased by 165,000 in the last month, well above the expected 60,000, while the unemployment rate fell to 4.1% from 4.2%. This stronger-than-expected labor market data is causing renewed pressure on gold prices, which recently t...
The Federal Reserve ended its rate pause in September 2026, with markets pricing in another hike by December. Historically, consumer staples stocks such as Costco, Walmart, Procter & Gamble, and Coca-Cola have shown resilience during rate hike cycles...
